← Company directory

Series B

LabGenius

AI antibody discovery

VerifiedSeries BLondon
Companies House
08183505
GLEIF LEI
Not matched
Latest evidence
2024-05-01
Evidence snapshot
2026-08-25
Funding signal3

Dated disclosed rounds · latest 2024-05-01

Procurement signal0

Exact award notices · latest No exact award match

Registry observationMatched

2026-08-01

Regional contextLondon

Jun 2026

Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.

Evidence timeline

5 dated observations

Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.

  1. RegistryRecord observation

    Status observed: Active

    Snapshot evidence only; this row does not claim the status changed on this date.

  2. RegistryRegistry fact

    Company incorporated

    LABGENIUS LIMITED · company 08183505

Latest disclosed round

Series B

Date
2024-05-01
Amount
GBP 35m
Sector
Biotech & techbio
Companies House
08183505
ONS region
London

Evidence status

Directory ready

Identity
Verified
Match
High — exact company number and aligned registered name
Operating status
active
Data origins
Core directory, Growth Network, Live Chris T D1

Capital network

9 linked investors

Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.

InvestorRoleDateSourceMatch / state
M Ventureslead2024-05-01Sifted ↗ · Tech.eu ↗reviewed canonical company and investor alias resolutionsource-linked · published
Air Street Capitalparticipant2026-08-25Sifted ↗reviewed canonical company and investor alias resolutionsource-linked · published
Atomicoparticipant2024-05-01Sifted ↗ · Tech.eu ↗reviewed canonical company and investor alias resolutionsource-linked · published
Backed VCparticipant2026-08-25Sifted ↗reviewed canonical company and investor alias resolutionsource-linked · published
Kindred Capitalparticipant2024-05-01Sifted ↗ · Tech.eu ↗ · Goodwinlaw ↗reviewed canonical company and investor alias resolutionsource-linked · published
LG Corpparticipant2024-05-01Sifted ↗ · Tech.eu ↗reviewed canonical company and investor alias resolutionsource-linked · published
Lux Capitalparticipant2024-05-01Sifted ↗ · Tech.eu ↗reviewed canonical company and investor alias resolutionsource-linked · published
Obvious Venturesparticipant2024-05-01Sifted ↗ · Tech.eu ↗reviewed canonical company and investor alias resolutionsource-linked · published
Octopus Venturesparticipant2024-05-01Sifted ↗ · Tech.eu ↗reviewed canonical company and investor alias resolutionsource-linked · published

Funding record

3 disclosed rounds

Open a dated round to move directly between the company, named investors and source publication.

DateStageAmountInvestorsNamed sources
2024-05-01Series B£35MOctopus Ventures · LG Corp · Atomico · Kindred Capital · Lux Capital · Obvious Ventures · 1 additional source-listed nameSifted ↗ · Tech.eu ↗
2020-10-29Series A extension$15M additional (Series A total $25M)Atomico · Lux Capital · Obvious Ventures · Kindred Capital · 1 additional source-listed nameTech.eu ↗ · Synbiobeta ↗
2019-10-22Series A$10M+ (also €11.5M)Lux Capital · Obvious Ventures · Air Street Capital · Kindred Capital · 4 additional source-listed namesTechCrunch ↗ · Forbes ↗

Companies House status and filing snapshot

LABGENIUS LIMITED

Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.

Registered record

Status
Active
Company type
Private Limited Company
Country of origin
United Kingdom
Incorporated
2012-08-17
Dissolved
Not applicable
Company number
08183505

Filing context

Accounts category
FULL
Accounts made up to
2024-12-31
Next accounts due
2026-09-30
Confirmation made up to
2025-09-08
Registry snapshot
2026-08-01
Live check
Bulk snapshot only
72110Research and experimental development on biotechnology

SourceCompanies HouseDate2026-08-01Matchexact Companies House numberStatepublished projection

Traceability

Source trail

Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.